id | C00002804 |
---|---|
Name | Chrysazin |
CAS RN | 117-10-2 |
Standard InChI | InChI=1S/C14H8O4/c15-9-5-1-3-7-11(9)14(18)12-8(13(7)17)4-2-6-10(12)16/h1-6,15-16H |
Standard InChI (Main Layer) | InChI=1S/C14H8O4/c15-9-5-1-3-7-11(9)14(18)12-8(13(7)17)4-2-6-10(12)16/h1-6,15-16H |
Phytochemical cluster | No. 62 |
---|---|
KCF-S cluster | No. 41 |
By standard InChI | CHEMBL53418 |
---|---|
By standard InChI Main Layer | CHEMBL53418 |
By LinkDB | C10312 |
---|
By CAS RN | C004315 |
---|
class name | count |
---|---|
asterids | 1 |
eudicotyledons | 1 |
Liliopsida | 1 |
family name | count |
---|---|
Rubiaceae | 1 |
Polygonaceae | 1 |
Xyridaceae | 1 |
KNApSAcK organism | *ID | *family | *plant class | *kingdom |
---|---|---|---|---|
Cinchona ledgeriana | 153742 | Rubiaceae | asterids | Viridiplantae |
Rheum palmatum | 137221 | Polygonaceae | eudicotyledons | Viridiplantae |
Xyris semifuscata | 75440 | Xyridaceae | Liliopsida | Viridiplantae |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
Q16637 | Survival motor neuron protein | Unclassified protein | CHEMBL53418 |
CHEMBL1613842
(1)
|
4 / 2 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | CHEMBL53418 |
CHEMBL1738312
(1)
|
0 / 0 |
Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | CHEMBL53418 |
CHEMBL1908087
(1)
|
0 / 0 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | CHEMBL53418 |
CHEMBL1794524
(1)
|
0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | CHEMBL53418 |
CHEMBL1614544
(2)
|
11 / 10 |
P16473 | Thyrotropin receptor | Glycohormone receptor | CHEMBL53418 |
CHEMBL1614281
(1)
CHEMBL1614361
(1)
|
3 / 2 |
P10828 | Thyroid hormone receptor beta | NR1A2 | CHEMBL53418 |
CHEMBL1794561
(1)
|
3 / 1 |
P68400 | Casein kinase II subunit alpha | Ck2 | CHEMBL53418 |
CHEMBL1063677
(1)
|
0 / 0 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | CHEMBL53418 |
CHEMBL1614166
(1)
|
1 / 0 |
Q9HAW7 | UDP-glucuronosyltransferase 1-7 | Enzyme | CHEMBL53418 |
CHEMBL1908084
(1)
|
0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | CHEMBL53418 |
CHEMBL1794311
(2)
|
2 / 3 |
Q9Y3R4 | Sialidase-2 | Enzyme | CHEMBL53418 |
CHEMBL1100507
(1)
|
0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | CHEMBL53418 |
CHEMBL1614458
(1)
|
0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | CHEMBL53418 |
CHEMBL1738606
(1)
|
0 / 0 |
P42858 | Huntingtin | Unclassified protein | CHEMBL53418 |
CHEMBL1613918
(1)
|
1 / 1 |
O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | CHEMBL53418 |
CHEMBL1908086
(1)
|
0 / 0 |
P10145 | Interleukin-8 | Secreted protein | CHEMBL53418 |
CHEMBL2114835
(1)
|
0 / 0 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | CHEMBL53418 |
CHEMBL1794293
(1)
|
5 / 3 |
P28482 | Mitogen-activated protein kinase 1 | Erk | CHEMBL53418 |
CHEMBL1614521
(2)
CHEMBL1613808
(1)
|
0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | CHEMBL53418 |
CHEMBL1613910
(1)
|
3 / 3 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | CHEMBL53418 |
CHEMBL1614038
(1)
|
2 / 2 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | CHEMBL53418 |
CHEMBL2114842
(1)
|
0 / 0 |
P03372 | Estrogen receptor | NR3A1 | CHEMBL53418 |
CHEMBL708330
(1)
CHEMBL708331
(1)
CHEMBL708332 (1) CHEMBL1794364 (1) CHEMBL1794542 (1) |
1 / 1 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | CHEMBL53418 |
CHEMBL1614240
(1)
|
0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | CHEMBL53418 |
CHEMBL1614211
(1)
|
0 / 0 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | CHEMBL53418 |
CHEMBL1908080
(1)
|
5 / 1 |
P10636 | Microtubule-associated protein tau | Unclassified protein | CHEMBL53418 |
CHEMBL1614421
(2)
CHEMBL1614502
(1)
|
4 / 3 |
P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | CHEMBL53418 |
CHEMBL1908083
(1)
|
0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | CHEMBL53418 |
CHEMBL2114890
(1)
|
0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | CHEMBL53418 |
CHEMBL1738442
(2)
|
0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | CHEMBL53418 |
CHEMBL1614364
(1)
|
1 / 1 |
Q92731 | Estrogen receptor beta | NR3A2 | CHEMBL53418 |
CHEMBL708330
(1)
CHEMBL708331
(1)
CHEMBL708332 (1) |
0 / 1 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
C004315 | 196 |
AHR
bHLHe76 |
aryl hydrocarbon receptor | danthron inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein] |
decreases reaction
/ increases activity |
protein |
19269596
|
C004315 | 9131 |
AIFM1
AIF CMTX4 COWCK COXPD6 PDCD8 |
apoptosis-inducing factor, mitochondrion-associated, 1 | danthron affects the localization of and results in increased expression of AIFM1 protein |
affects localization
/ increases expression |
protein |
21126053
|
C004315 | 9131 |
AIFM1
AIF CMTX4 COWCK COXPD6 PDCD8 |
apoptosis-inducing factor, mitochondrion-associated, 1 | danthron results in increased expression of AIFM1 mRNA |
increases expression
|
mRNA |
21126053
|
C004315 | 213 |
ALB
PRO0883 PRO0903 PRO1341 |
albumin | danthron binds to ALB protein |
affects binding
|
protein |
16404478
|
C004315 | 22926 |
ATF6
ATF6A |
activating transcription factor 6 | danthron results in increased expression of ATF6 protein |
increases expression
|
protein |
21126053
|
C004315 | 581 |
BAX
BCL2L4 |
BCL2-associated X protein | danthron results in increased expression of BAX protein |
increases expression
|
protein |
21126053
|
C004315 | 596 |
BCL2
Bcl-2 PPP1R50 |
B-cell CLL/lymphoma 2 | danthron results in decreased expression of BCL2 protein |
decreases expression
|
protein |
21126053
|
C004315 | 598 |
BCL2L1
BCL-XL/S BCL2L BCLX BCLXL BCLXS Bcl-X PPP1R52 bcl-xL bcl-xS |
BCL2-like 1 | danthron results in decreased expression of BCL2L1 protein |
decreases expression
|
protein |
21126053
|
C004315 | 598 |
BCL2L1
BCL-XL/S BCL2L BCLX BCLXL BCLXS Bcl-X PPP1R52 bcl-xL bcl-xS |
BCL2-like 1 | danthron results in increased expression of BCL2L1 protein |
increases expression
|
protein |
21126053
|
C004315 | 637 |
BID
FP497 |
BH3 interacting domain death agonist | danthron results in increased expression of BID protein |
increases expression
|
protein |
21126053
|
C004315 | 329 |
BIRC2
API1 HIAP2 Hiap-2 MIHB RNF48 c-IAP1 cIAP1 |
baculoviral IAP repeat containing 2 | danthron results in decreased expression of BIRC2 protein |
decreases expression
|
protein |
21126053
|
C004315 | 330 |
BIRC3
AIP1 API2 CIAP2 HAIP1 HIAP1 MALT2 MIHC RNF49 c-IAP2 |
baculoviral IAP repeat containing 3 | danthron results in increased expression of BIRC3 protein |
increases expression
|
protein |
21126053
|
C004315 | 332 |
BIRC5
API4 EPR-1 |
baculoviral IAP repeat containing 5 | danthron results in decreased expression of BIRC5 protein |
decreases expression
|
protein |
21126053
|
C004315 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [danthron results in increased activity of CASP3 protein] |
decreases reaction
/ increases activity |
protein |
21126053
|
C004315 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | danthron results in increased activity of and results in increased expression of CASP3 protein |
increases activity
/ increases expression |
protein |
21126053
|
C004315 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | danthron results in increased expression of CASP3 mRNA |
increases expression
|
mRNA |
21126053
|
C004315 | 841 |
CASP8
ALPS2B CAP4 Casp-8 FLICE MACH MCH5 |
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [danthron results in increased activity of CASP8 protein] |
decreases reaction
/ increases activity |
protein |
21126053
|
C004315 | 841 |
CASP8
ALPS2B CAP4 Casp-8 FLICE MACH MCH5 |
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) | danthron results in increased activity of and results in increased expression of CASP8 protein |
increases activity
/ increases expression |
protein |
21126053
|
C004315 | 841 |
CASP8
ALPS2B CAP4 Casp-8 FLICE MACH MCH5 |
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) | danthron results in increased expression of CASP8 mRNA |
increases expression
|
mRNA |
21126053
|
C004315 | 842 |
CASP9
APAF-3 APAF3 ICE-LAP6 MCH6 PPP1R56 |
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [danthron results in increased activity of CASP9 protein] |
decreases reaction
/ increases activity |
protein |
21126053
|
C004315 | 842 |
CASP9
APAF-3 APAF3 ICE-LAP6 MCH6 PPP1R56 |
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) | danthron results in increased activity of and results in increased expression of CASP9 protein |
increases activity
/ increases expression |
protein |
21126053
|
C004315 | 842 |
CASP9
APAF-3 APAF3 ICE-LAP6 MCH6 PPP1R56 |
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) | danthron results in increased expression of CASP9 mRNA |
increases expression
|
mRNA |
21126053
|
C004315 | 54205 |
CYCS
CYC HCS THC4 |
cytochrome c, somatic | danthron affects the localization of and results in increased expression of CYCS protein |
affects localization
/ increases expression |
protein |
21126053
|
C004315 | 1649 |
DDIT3
CEBPZ CHOP CHOP-10 CHOP10 GADD153 |
DNA-damage-inducible transcript 3 | danthron results in increased expression of DDIT3 protein |
increases expression
|
protein |
21126053
|
C004315 | 56616 |
DIABLO
DFNA64 SMAC |
diablo, IAP-binding mitochondrial protein | danthron results in increased expression of DIABLO protein |
increases expression
|
protein |
21126053
|
C004315 | 2021 |
ENDOG
|
endonuclease G | danthron affects the localization of and results in increased expression of ENDOG protein |
affects localization
/ increases expression |
protein |
21126053
|
C004315 | 2021 |
ENDOG
|
endonuclease G | danthron results in increased expression of ENDOG mRNA |
increases expression
|
mRNA |
21126053
|
C004315 | 355 |
FAS
ALPS1A APO-1 APT1 CD95 FAS1 FASTM TNFRSF6 |
Fas cell surface death receptor | danthron results in increased expression of FAS protein |
increases expression
|
protein |
21126053
|
C004315 | 356 |
FASLG
ALPS1B APT1LG1 APTL CD178 CD95-L CD95L FASL TNFSF6 |
Fas ligand (TNF superfamily, member 6) | danthron results in increased expression of FASLG protein |
increases expression
|
protein |
21126053
|
C004315 | 3309 |
HSPA5
BIP GRP78 MIF2 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | danthron results in increased expression of HSPA5 protein |
increases expression
|
protein |
21126053
|
C004315 | 6647 |
SOD1
ALS ALS1 IPOA SOD hSod1 homodimer |
superoxide dismutase 1, soluble (EC:1.15.1.1) | danthron results in decreased expression of SOD1 protein |
decreases expression
|
protein |
21126053
|
C004315 | 6648 |
SOD2
IPOB MNSOD MVCD6 |
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) | danthron results in decreased expression of SOD2 protein |
decreases expression
|
protein |
21126053
|
C004315 | 8743 |
TNFSF10
APO2L Apo-2L CD253 TL2 TRAIL |
tumor necrosis factor (ligand) superfamily, member 10 | danthron results in increased expression of TNFSF10 protein |
increases expression
|
protein |
21126053
|
C004315 | 331 |
XIAP
API3 BIRC4 IAP-3 ILP1 MIHA XLP2 hIAP-3 hIAP3 |
X-linked inhibitor of apoptosis | danthron results in decreased expression of XIAP protein |
decreases expression
|
protein |
21126053
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
%606641 | Body mass index; bmi |
P37231
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#218800 | Crigler-najjar syndrome, type i |
P22309
|
#606785 | Crigler-najjar syndrome, type ii |
P22309
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#143500 | Gilbert syndrome |
P22309
|
#137800 | Glioma susceptibility 1; glm1 |
P37231
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#143100 | Huntington disease; hd |
P42858
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#601665 | Obesity |
P37231
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#172700 | Pick disease of brain |
P10636
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
KEGG | disease name | UniProt |
---|---|---|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
Q92731 (marker) |
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
|
H00032 | Thyroid cancer |
P37231
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00059 | Huntington's disease (HD) |
P42858
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
Q16637 (related) |
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q9NUW8
(related)
|